IEEE Engineering in Medicine and Biology Society Announces the Launch of the Journal of Translational Engineering in Health and Medicine
Piscataway, NJ (PRWEB) July 16, 2013 -- The IEEE Engineering in Medicine and Biology Society (EMBS) today announced the launch of the Journal of Translational Engineering in Health and Medicine (JTEHM). The open-access journal was created to support the movement of biotechnological innovations from idea to clinical trials and ultimately to commercialization, and will foster global conversation and interdisciplinary collaborations on innovative translational research in health and medicine. By providing this critically important industry resource, EMBS endeavors to improve the practice of engineering in translational medicine and to serve as a focal point for the growing community.
Via its website, health.embs.org, JTEHM publishes cutting-edge biomedical engineering innovations that bridge the clinical and engineering worlds, along with a variety of interactive content including video, blogs, lively commentary, and other features. All of the work published in JTEHM shares a focus on solutions to healthcare needs from the biomedical engineering, clinical engineering, and medical communities. JTEHM publishes results and best practices from these translational efforts and serves as a community hub for researchers, clinicians, and developers who are addressing challenges in technology development, commercialization, and deployment for better global healthcare.
“We believe that the Journal of Translational Engineering in Health and Medicine fills a vital need in the industry and provides a vehicle for the consilience of engineering, medicine, and health. Such translational work is critical in moving the technology frontier into the clinical environment to improve clinical practice and human health,” said Clifford Dasco, MD, co-editor-in-chief and Professor of Cellular and Molecular Biology and Medicine at Baylor College of Medicine and Distinguished Research Professor, College of Technology, University of Houston. “Translation used to be covered under the phrase ‘from the bench to the bedside.’ Now we know that there is a far greater world beyond the bed.”
“The long pathway from technology innovation to clinical practice involves tremendous collaborative synergy among experts and researchers in basic and applied sciences, engineering, computing and information technologies, and biological, behavioral and medical sciences. It also entails the active involvement of entrepreneurs and investors along with leaders in industry, healthcare, and public policy,” said Atam Dhawan, PhD, co-editor-in-chief and Distinguished Professor of Electrical and Computer Engineering and Interim Dean, Albert Dorman Honors College, New Jersey Institute of Technology.
IEEE EMBS chose to offer JTEHM in an open-access format to maximize global readership, decrease time to publication, and increase the breadth of articles that are published. The journal’s open-source, continuous-publication platform allows multimedia presentation of clinically significant translational technology breakthroughs with editorial blogs and comments from experts, entrepreneurs, and clinicians. The papers published in JTEHM are accessible through IEEE Xplore and in downloadable PDF versions that will include additional material such as commentary and video. In the future, papers will also be indexed in PubMed.
Researchers are invited to submit papers with their research findings and clinical translation studies for publication in JTEHM. The editorial board also welcomes submissions from industry, policy makers, and the investment community. For questions about the suitability of work for JTEHM, please send an abstract to editors(at)health(dot)embs(dot)org. JTEHM publishes articles on subjects including, but not limited to, the following:
• Medical Devices and Systems
• Nano-biosensors and Biosystems
• Medical Imaging and Diagnostic Radiology
• Cardiovascular Devices and Systems
• Neurovascular Devices and Systems
• Rehabilitation Devices and Systems
• Surgical and Interventional Devices
• Bio and Surgical Robotics
• Wearable Sensors and Health Monitoring Systems
• Point-of-Care Technologies
• Wireless and Communication Technologies for Bio-Information Systems
• Electronic Medical Records and Medical Information Systems
• Clinical Ideation
• Clinical Trials
• Clinical Commercialization
• Clinical Engineering
• Global Health
• Harsh Environments
• Hematology and Hemostasis
• Metabolics
• Oncology
• Risk and Uncertainty
• Social Determinants of Health
• Law, Ethics, and Policy
• Medicine
About IEEE EMBS
IEEE Engineering in Medicine and Biology Society (EMBS) is the world's largest international society of Biomedical Engineers. With more than 46 percent of its 9,100 members residing in some 97 countries around the world, it's a true global connection, providing access to the most fascinating people, practices, information, ideas, opinion and fellowship from one of science's fastest growing fields: biomedical engineering. From formalized mathematical theory through experimental science, from technological development to practical clinical applications, IEEE EMBS members support scientific, technological, and educational activities as they apply to the concepts and methods of the physical and engineering sciences in biology and medicine. By working together, we can transform and revolutionize the future of medicine and healthcare. For more information about the EMBS, please visit http://www.embs.org. You can also connect with us on Facebook, Twitter and LinkedIn.
About IEEE
IEEE, the world’s largest technical professional association, is dedicated to advancing technology for the benefit of humanity. Through its highly cited publications, conferences, technology standards, and professional and educational activities, IEEE is the trusted voice on a wide variety of areas ranging from aerospace systems, computers and telecommunications to biomedical engineering, electric power and consumer electronics. Learn more at http://www.ieee.org.
Media Contact:
Nicole Randall
nicole.randall(at)live(dot)com
Tel: +1 310.691.0849
Nicole Randall, +1 310-691-0849, [email protected]
Share this article